These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31838901)

  • 41. Integrating virtual screening and combinatorial chemistry for accelerated drug discovery.
    López-Vallejo F; Caulfield T; Martínez-Mayorga K; Giulianotti MA; Nefzi A; Houghten RA; Medina-Franco JL
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):475-87. PubMed ID: 21521151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.
    Giordano A; Forte G; Massimo L; Riccio R; Bifulco G; Di Micco S
    Eur J Med Chem; 2018 May; 152():253-263. PubMed ID: 29730188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of novel rho kinase inhibitors using energy based pharmacophore modeling, shape-based screening, in silico virtual screening, and biological evaluation.
    Mishra RK; Alokam R; Singhal SM; Srivathsav G; Sriram D; Kaushik-Basu N; Manvar D; Yogeeswari P
    J Chem Inf Model; 2014 Oct; 54(10):2876-86. PubMed ID: 25254429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
    Zhang L; Wang X; Li X; Xu W
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
    Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
    Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
    Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
    Xiao T; Qi X; Chen Y; Jiang Y
    Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
    Aston NM; Bamborough P; Buckton JB; Edwards CD; Holmes DS; Jones KL; Patel VK; Smee PA; Somers DO; Vitulli G; Walker AL
    J Med Chem; 2009 Oct; 52(20):6257-69. PubMed ID: 19772287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
    Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
    Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro.
    Chen X; Lu Z; Xiao J; Xia W; Pan Y; Xia H; Chen YH; Zhang H
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small molecule inhibitors of the prostate cancer target KMT2D.
    Yu Q; Liao Z; Liu D; Xie W; Liu Z; Liao G; Wang C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):540-547. PubMed ID: 32988590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.
    Ramamurthy VP; Ramalingam S; Gediya L; Kwegyir-Afful AK; Njar VC
    Oncotarget; 2015 Feb; 6(5):3195-210. PubMed ID: 25605250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Stress Kinase p38α as a Target for Cancer Therapy.
    Igea A; Nebreda AR
    Cancer Res; 2015 Oct; 75(19):3997-4002. PubMed ID: 26377941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.